February 11, 2026-
Highlights from the fourth quarter
- Complete income rose to $105.7 billion, a rise of 8.2% in comparison with final 12 months
- GAAP diluted earnings per share of $2.30 and adjusted earnings per share of $1.09
Highlights of the complete 12 months
- Complete revenues rose to a file excessive of $402.1 billion, up 7.8% from final 12 months
- GAAP diluted earnings per share of $1.39 and adjusted earnings per share of $6.75
- Generated money circulate from operations of $10.6 billion
Operational highlights
- CVS Pharmacy® has efficiently accomplished the transition to cost-based reimbursement for its Business, Third-Get together Low cost, Medicare and Medicaid companies.
- Etna® continues to enhance the expertise for healthcare professionals and their sufferers, with greater than 95% of all eligible prior authorizations authorized inside 24 hours, with many accomplished instantly.
- Healthcare model® shut out 2025 with important buyer wins and robust retention, offering momentum for 2026.
Steering for the complete 12 months 2026
- Up to date money circulate from working steering from a minimal of $10.0 billion to a minimal of $9.0 billion
- Confirmed GAAP earnings per share steering of $5.94 to $6.14
- Confirmed adjusted EPS steering from $7.00 to $7.20
Proceed studying